SHAROKY MELVIN MD
SEC Form 4 insider trading activity
SHAROKY MELVIN MD has filed 6 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Aug 19, 2026.
On the most recent filing, SHAROKY MELVIN MD is listed as Director at INSMED Inc. Inside the rolling window, SHAROKY MELVIN MD reported no open-market purchases and 2 open-market sales totaling $4.7M in INSM. The largest disclosed transaction in the window is a sale of 20,000 INSM shares on Dec 5, 2025, worth $4.1M.
Companies traded
Other insiders at INSM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 12, 2025 | INSM | Sale | $1.5M |
Frequently asked questions
How many SEC Form 4 filings has SHAROKY MELVIN MD made?
SHAROKY MELVIN MD has filed 6 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.
Which companies does SHAROKY MELVIN MD trade?
SHAROKY MELVIN MD has filed SEC Form 4 disclosures for 1 company, including INSM.
When was SHAROKY MELVIN MD's most recent SEC Form 4 filing?
SHAROKY MELVIN MD's most recent SEC Form 4 filing on Tracefour is dated Aug 19, 2026.
What is SHAROKY MELVIN MD's total buy and sell value in the current window?
Inside the rolling retention window, SHAROKY MELVIN MD bought $0 and sold $4.7M based on SEC Form 4 filings.
What was SHAROKY MELVIN MD's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 20,000 INSM shares on 2025-12-05, worth $4.1M, per SEC Form 4 filings.